Bank Julius Baer & Co. Ltd, Zurich Biogen Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

  • $25.6 Billion
  • Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Biogen Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 34 shares of BIIB stock, worth $5,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 853 96.01%
Holding current value
$5,368
Previous $197,000 96.95%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $154,848 - $193,939
-819 Reduced 96.01%
34 $6,000
Q2 2024

Aug 14, 2024
SELL
$190.52 - $236.72 $220,050 - $273,411
-1,155 Reduced 57.52%
853 $197,000
Q1 2024

May 14, 2024
BUY
$212.02 - $267.71 $62,757 - $79,242
296 Added 17.29%
2,008 $432,000
Q4 2023

May 16, 2024
SELL
$222.59 - $267.94 $65,886 - $79,310
-296 Reduced 14.74%
1,712 $443,000
Q4 2023

Feb 02, 2024
BUY
$222.59 - $267.94 $11,797 - $14,200
53 Added 3.19%
1,712 $443,000
Q3 2023

Nov 13, 2023
SELL
$253.3 - $285.89 $106,639 - $120,359
-421 Reduced 20.24%
1,659 $426,000
Q2 2023

Jul 24, 2023
BUY
$275.25 - $318.06 $572,520 - $661,564
2,080 New
2,080 $592,000
Q1 2023

May 11, 2023
SELL
$256.56 - $292.34 $256,046 - $291,755
-998 Reduced 45.89%
1,177 $327,000
Q4 2022

Jan 24, 2023
BUY
$252.44 - $306.72 $8,582 - $10,428
34 Added 1.59%
2,175 $602,000
Q3 2022

Nov 04, 2022
BUY
$194.69 - $268.46 $41,663 - $57,450
214 Added 11.11%
2,141 $572,000
Q2 2022

Jul 22, 2022
SELL
$187.54 - $223.02 $28,131 - $33,453
-150 Reduced 7.22%
1,927 $393,000
Q1 2022

May 09, 2022
SELL
$193.77 - $244.14 $48,442 - $61,035
-250 Reduced 10.74%
2,077 $437,000
Q4 2021

Feb 15, 2022
SELL
$223.92 - $287.77 $89,120 - $114,532
-398 Reduced 14.61%
2,327 $558,000
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $560,037 - $730,349
-1,979 Reduced 42.07%
2,725 $771,000
Q2 2021

Jul 23, 2021
SELL
$259.0 - $414.71 $14.8 Million - $23.6 Million
-56,987 Reduced 92.37%
4,704 $1.63 Million
Q1 2021

May 10, 2021
SELL
$242.95 - $284.63 $949,934 - $1.11 Million
-3,910 Reduced 5.96%
61,691 $17.3 Million
Q4 2020

Feb 24, 2021
BUY
$236.26 - $355.63 $10.8 Million - $16.3 Million
45,861 Added 232.33%
65,601 $16.1 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $18.4 Million - $27.8 Million
-78,055 Reduced 79.81%
19,740 $16.1 Million
Q3 2020

Nov 10, 2020
SELL
$264.77 - $305.71 $3.49 Million - $4.03 Million
-13,176 Reduced 11.87%
97,795 $27.7 Million
Q2 2020

Aug 12, 2020
SELL
$258.66 - $342.55 $2.61 Million - $3.46 Million
-10,090 Reduced 8.33%
110,971 $29.6 Million
Q1 2020

May 13, 2020
BUY
$268.85 - $341.04 $32.5 Million - $41.3 Million
121,061 New
121,061 $38.3 Million

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email